share_log

关于对北京康辰药业股份有限公司2023年度审计报告带强调事项段的无保留意见涉及事项已消除的审核报告

Regarding the unqualified opinion with emphasis on matters related to the audit report of Beijing Konruns Pharmaceutical Co., Ltd. for the year 2023, the relevant issues have been eliminated in the audit report.

SZSI ·  Jul 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more